The U.S. Supreme Court's decision to no longer give deference to government agency interpretations could lead to challenges against U.S....

The Patent Trial and Appeal Board (PTAB) has seen a steady increase in the invalidation rate of patents in the past five years, reaching...

Judge Alan D. Albright, sitting by designation at the Federal Circuit, penned his inaugural appellate decision in Apple v. Omni MedSci on...

The U.S. Patent & Trademark Office (PTO) has introduced new rules enhancing the independence of administrative patent judge (APJ) panels....

So far in 2024, Director Review decisions have shifted from primarily sua sponte DRs to party-initiated DRs. In addition, there has been...

Lynk Labs has presented an argument to the Federal Circuit, asserting that patent applications should only be utilized to invalidate...

United States Patent and Trademark Office Director Kathi Vidal's recent decision emphasizes the importance of General Plastic factor 1 in...

The Patent Trial and Appeal Board (PTAB) recently made a notable pair of decisions invalidating patents held by Wildseed Mobile LLC as...

The NPRM proposals align with interim guidance on requesting director review for key AIA trial decisions. Following the Arthrex v. Smith...

The NPRM introduces a significant procedural change by creating a separate briefing process for discretionary denials in post-grant...